DAFTAR PUSTAKA

1. Purnomo Basuki B. Dasar – dasar Urologi. Edisi 3. Jakarta: Sagung Seto;

2011.
2. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer
Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet].
Lyon, France: International Agency for Research on Cancer, 2013.
http://globocan.iarc.fr (27 January 2015, date last accessed).
3. Akaza H, Hinotsu S, Cooperberg MR, et al. Sixth joint meeting of J-CaP and
CaPSURE—a multinational perspective on prostate cancer manage- ment and
patient outcomes. Jpn J Clin Oncol 2013;43:56–66.
4. Umbas R, Hardjowijoto S, Mochtar CA, et al. Guidelines on Prostate Cancer
Management of the Indonesian Urological Association. Jakarta: Indonesian
Urological Association, 2011. ISBN: 978-979-25-4288-2 (in Indonesian).
5. Cihan YB, Arslan A, Ergul MA. Subtypes of White Blood Cells in Patients
with Prostate Cancer or Benign Prostatic Hyperplasia and Healthy
Individuals.Turkey:Asian Pacific Journal Cancer, 2013;8:4779-4783
6. Dharma R, Immanuel S, Wirawan R. Penilaian Hasil Pemeriksaan
Hematologi Rutin. Cermin Dunia Kedokteran. 1983; 30: 28-31.
7. Ding H, Fan S, Zhang L, Hao Z, Liang C. Does Prostatitis increase the risk of
Prostate Cancer? A meta-analysis. Int J Clin Exp Med.2017;10(3):4798-4808
8. Young JL, Soper DE. Urinalysis and Urinary Tract Infection: update for
clinicans. Medical University of South Carolina. 2001;9:249-255
9. Snell RS. Anatomi Klinis Berdasarkan Sistem. Jakarta. EGC. 2011
10. Kumar V, Ramzi SC, dan Stanley LR. Buku Ajar Patologi 2. Edisi 7. Jakarta:
EGC.2012
11. Mottet N, Bellmunt J, Briers E, Bolla M, Cornford P, Santis M, Henry A, et
al. Guidelines on Prostate Cancer.Europe: European Association of Urology,
2016.
12. Mochtar CA, Atmoko W, Umbas R, Hamid Agus RAH. Prostate cancer
detection rate in Indonesian men.Jakarta: Asian Journal of Surgery,2017.
13. Daniyal M, Siddiqui ZA, Akram M, Asif HM, Sultana S, Khan A.
Epidemiology, Etiology, Diagnosis and Treatment of Prostate Cancer.
Pakistan.Asian Pacific Journal Cancer.2014; 15(22), 9575-9578.
14. Shen MM and Shen CA. Molecular Genetic of Prostate Cancer : New
Prospects for Old Challenges. Genes Dev 2010;24: 1967-2000
15. Xia SJ, Di Cui, Qi Jiang. An Overview of Prostate Disease and Their
Characteristics Specific to Asian men. Asian Journal of Andrology 2012; 14:
458 – 464
16. Hoffman RM. Screening for Prostate Cancer. New Mexico. New England
Journal of Medicine. 2011;365:2013-9.
17. Applewhite JC, Matlaga BR, McCullough DL, Hall MC. Transrectal
Ultrasound and Biopsy in the Early Diagnosis of Prostate Cancer. Winston-
Salem. Cancer Center.2001; 8(2)
18. Eiro N, Vizoso FJ. Inflammation and Cancer. World journal of
gastrointestinal surgery.2012;4(3): 62.
19. Fujita K, Imamura R, Tanigawa G, Nakagawa M, Hayashi T, Kishimoto N et
al. Low Serum Neutrophil Count Predicts a Positive Prostate Biopsy. Prostate
Cancer and Prostatic Disease. 2012; 15(4): 386-390.
20. Fatmah. Respon imunitas yang rendah pada tubuh manusia usia lanjut.
Makara Kesehatan. 2006; 10:47-53
21. Foster AD, Sivarapatna A, Gress RE. The Aging immune system and its
relationship with cancer. National Cancer Institute.October 2011; 7(5): 707-
718
22. Jiang J, Li J, Zhang Y, Zhu H, Liu J, Pumill. The Role of Prostatitis in
Prostate Cancer: Meta-Analysis. December. 2013;8.
23. Seputra KP, Tarmono, Noegroho BS, Mochtar CA, Wahyudi I, Renaldo J, et
al. Guideline Penatalaksanaan Infeksi Saluran Kemih dan Genitalia Pria
2015. Ikatan Ahli Urologi Indonesia.Surabaya. Ikatan Ahli Urologi Indonesia.
2015
24. Soeliongan S, Porotu’o J, Sumolang SA. Pola Bakteri Pada Penderita Infeksi
Saluran Kemih di BLU RSUP PROF. dr. R. D. Kandou Manado. Bagian
 Mikrobiologi Fakultas Kedokteran Universitas Sam Ratulangi. 2013; 1(1).
597-601.
25. Darsono PV, Mahdiyah D, Sari M. Gambaran Karakteristik Ibu Hamil Yang
Mengalami Infeksi Saluran Kemih (ISK) di Wilayah Kerja Puskesmas
Pekauman Banjarmasin. Banjarmasin. Dinamika Kesehatan.2016; 1(1).
26. Walsh C, Collyns T. The Pathophysiology of Urinary Tract Infections. United
Kingdom. Elsevier.2017
27.
28. Indonesian Society of Urologic Oncology (ISUO). ISUO Meeting 2011.2011
29. Kelompok Kerja Kanker Urologi RS. Cipto Mangunkusumo – RS. Kanker
Dharmais. Panduan pengelolaan kanker prostat. Interna Publishing,2009.
30. Umbas R, Muchtar C, Hamid R. Terapi radikal pada penderita kanker prostat:
tindak lanjut jangka panjang dan factor prediksi survival. Indonesian Journal
Cancer.2010; 4: 55-60
31. Safriadi F. Karakteristik dan pola penanganan Kanker prostat di RS Hasan
Sadikin Bandung. Indonesian Journal Cancer.
32. Mahadi E, Widjanarko S. Penanganan Karsinoma Prostat di RSUD dr.
Moewardi Surakarta selama Januari 2000-Desember 2006. Indonesian
Journal Urology.2009; 16:25-28
33. Hsing AW, Anand PC. Prostate Cancer Epidemiology. Frontiers in
Bioscience 11. 2006: 1388-1413
34. Prostate Cancer. Meetdoctor;(online). (http://meetdoctor.com/topic/kanker-
prostat) diakses 11 Desember 2017
35. Okolo CA, Okinosum OM, Shittu OB, et al. Correlation of serum PSA and
Gleason score in Nigerian man with prostate cancer. African Journal of
Urology 2008; vol 14: no 1: 15-22
36. Shen MM and Shen CA. Molecular Genetic of Prostate Cancer : New
Prospects for Old Challenges. Genes Dev 2010;24: 1967-2000
37. Xia SJ, Di Cui, Qi Jiang. An Overview of Prostate Disease and Their
Characteristics Specific to Asian men. Asian Journal of Andrology 2012; 14:
458 – 464
38. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-
specific antigen as a serum marker for adenocarcinoma of the prostate. N
Engl J Med 1987 ;317(15):909-16.
39. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan
RC, et al. Comparison of digital rectal examination and serum prostate
specific antigen in the early detection of prostate cancer: result of a
multicentre clinical trial of 6,630 men. J Urol 1994;151(5):1283-90
40. David G, Donal J, Rexhepaj E, et al. Leukocyte complexity predict beast
cancer survival and functionaly regulates response to chemotherapy.
American Association for Cancer Research.2011.
41. Amandito, Radhian, Viryawan C, Santoso F, et al. The characteristics of
breast cancer patients in “Dharmais” hospital national cancer, Center Jakarta
Based on occupational and environmental status. Indonesia Journal of
Cancer, 2013; 7(2):54-58.
42. Othieno A, Waweru A. and Nyabola LO. Chemotherapy-induced as a
prognostic factor in patients with malignant disease undergoing
chemotherapy. Cancer Chemotherapy Pharmacol.2011.
43. Kim, Ryungsa, Emi M and Tanabe K. Cancer immunoeding from immune
surveillance to immune escape. Black Well Publishing
Immunology.2012;121:1-14
44. Alenzi, Faris Q, Alenzi BQ and Ahmad SY. The haemopoietic stem cell:
between apoptosis and self renewal. Yale J Bio and Med, 2013;82:7-8.
45. Su LM. Early diagnosis and treatment of cancer: prostate cancer.
Philadelphia: Elsevier Saunders, 2009
46. Poppy, Kumala, dkk. Kamus Kedokteran Dorland, copy editor edisi bahasa :
Dyah Nuswantari. Edisi 2005. Jakarta: EGC, 1998.
47. Hurlock EB. Psikologi perkembangan: suatu pendekatan sepanjang rentang
kehidupan. Surabaya : Erlangga, 2002.
48. Departemen Kesehatan RI. Profil Kesehatan Indonesia 2011. Jakarta:
Kementerian Kesehatan Republik Indonesia, 2012.
49. Dorshkind K, Susan S. Age-associated declines in immune system
development and function. Curr Opin Immunol. Aug 2009; 21(4): 404-407.
50. Fatmah. Respon imunitas yang rendah pada tubuh manusia usia lanjut.
Makara Kesehatan. 2006; 10:47-53.
51. Foster AD, Sivarapatna A, Gress RE. The Aging immune system and its
relationship with cancer.National Cancer Institute.October 2011; 7(5): 707-
718